{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:38:27Z","timestamp":1792636707744,"version":"4.5.0"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Anesth Analg Crit Care"],"DOI":"10.1186\/s44158-026-00408-5","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T11:14:44Z","timestamp":1785150884000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacology of vasopressors and inotropes during extracorporeal membrane oxygenation"],"prefix":"10.1186","volume":"6","author":[{"given":"Hannah M.","family":"Brinkman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamel P.","family":"Ortoleva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail G.","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic V.","family":"Pisano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan G.","family":"Ripoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel J.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troy G.","family":"Seelhammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary A.","family":"Kraybill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Elmadhoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Bottussi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Leone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica D.","family":"Wittwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena Giovanna","family":"Bignami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacopo","family":"D\u2019Andria Ursoleo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick M.","family":"Wieruszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"key":"408_CR1","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1007\/s00392-020-01781-z","volume":"110","author":"CN Lang","year":"2021","unstructured":"Lang CN, Kaier K, Zotzmann V, Stachon P, Pottgiesser T, Von Zur Muehlen C et al (2021) Cardiogenic shock: incidence, survival and mechanical circulatory support usage 2007\u20132017-insights from a national registry. Clin Res Cardiol 110:1421\u20131430. https:\/\/doi.org\/10.1007\/s00392-020-01781-z","journal-title":"Clin Res Cardiol"},{"key":"408_CR2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.021061","volume":"10","author":"M Osman","year":"2021","unstructured":"Osman M, Syed M, Patibandla S, Sulaiman S, Kheiri B, Shah MK et al (2021) Fifteen\u2010year trends in incidence of cardiogenic shock hospitalization and in\u2010hospital mortality in the United States. J Am Heart Assoc 10:e021061. https:\/\/doi.org\/10.1161\/JAHA.121.021061","journal-title":"J Am Heart Assoc"},{"key":"408_CR3","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1016\/S0140-6736(24)01818-X","volume":"404","author":"E L\u00fcsebrink","year":"2024","unstructured":"L\u00fcsebrink E, Binzenh\u00f6fer L, Adamo M, Lorusso R, Mebazaa A, Morrow DA et al (2024) Cardiogenic shock. Lancet 404:2006\u20132020. https:\/\/doi.org\/10.1016\/S0140-6736(24)01818-X","journal-title":"Lancet"},{"key":"408_CR4","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1161\/CIRCULATIONAHA.122.062949","volume":"147","author":"P Ostadal","year":"2023","unstructured":"Ostadal P, Rokyta R, Karasek J, Kruger A, Vondrakova D, Janotka M et al (2023) Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: results of the ECMO-CS randomized clinical trial. Circulation 147:454\u2013464. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.062949","journal-title":"Circulation"},{"key":"408_CR5","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1056\/NEJMoa2307227","volume":"389","author":"H Thiele","year":"2023","unstructured":"Thiele H, Zeymer U, Akin I, Behnes M, Rassaf T, Mahabadi AA et al (2023) Extracorporeal life support in infarct-related cardiogenic shock. N Engl J Med 389:1286\u20131297. https:\/\/doi.org\/10.1056\/NEJMoa2307227","journal-title":"N Engl J Med"},{"key":"408_CR6","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/S2213-2600(23)00137-6","volume":"11","author":"CJW Low","year":"2023","unstructured":"Low CJW, Ramanathan K, Ling RR, Ho MJC, Chen Y, Lorusso R et al (2023) Extracorporeal cardiopulmonary resuscitation versus conventional cardiopulmonary resuscitation in adults with cardiac arrest: a comparative meta-analysis and trial sequential analysis. Lancet Respir Med 11:883\u2013893. https:\/\/doi.org\/10.1016\/S2213-2600(23)00137-6","journal-title":"Lancet Respir Med"},{"key":"408_CR7","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1056\/NEJMoa2204511","volume":"388","author":"MM Suverein","year":"2023","unstructured":"Suverein MM, Delnoij TSR, Lorusso R, Brandon Bravo Bruinsma GJ, Otterspoor L, Elzo Kraemer CV et al (2023) Early extracorporeal CPR for refractory out-of-hospital cardiac arrest. N Engl J Med 388:299\u2013309. https:\/\/doi.org\/10.1056\/NEJMoa2204511","journal-title":"N Engl J Med"},{"key":"408_CR8","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1053\/j.jvca.2024.02.028","volume":"38","author":"J Ortoleva","year":"2024","unstructured":"Ortoleva J, Dalia AA, Pisano DV, Shapeton A (2024) Diagnosis and management of vasoplegia in temporary mechanical circulatory support: a narrative review. J Cardiothorac Vasc Anesth 38:1378\u20131389. https:\/\/doi.org\/10.1053\/j.jvca.2024.02.028","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"408_CR9","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1097\/MAT.0000000000001344","volume":"67","author":"A (Sacha)C Richardson","year":"2021","unstructured":"Richardson A (Sacha)C, Tonna JE, Nanjayya V, Nixon P, Abrams DC, Raman L et al (2021) Extracorporeal cardiopulmonary resuscitation in adults. Interim guideline consensus statement from the Extracorporeal Life Support Organization. ASAIO J 67:221\u2013228. https:\/\/doi.org\/10.1097\/MAT.0000000000001344","journal-title":"ASAIO J"},{"key":"408_CR10","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1097\/MAT.0000000000001510","volume":"67","author":"R Lorusso","year":"2021","unstructured":"Lorusso R, Shekar K, MacLaren G, Schmidt M, Pellegrino V, Meyns B et al (2021) ELSO Interim guidelines for venoarterial extracorporeal membrane oxygenation in adult cardiac patients. ASAIO J 67:827\u2013844. https:\/\/doi.org\/10.1097\/MAT.0000000000001510","journal-title":"ASAIO J"},{"key":"408_CR11","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/MAT.0000000000001630","volume":"68","author":"EF Gajkowski","year":"2022","unstructured":"Gajkowski EF, Herrera G, Hatton L, Velia Antonini M, Vercaemst L, Cooley E (2022) ELSO guidelines for adult and pediatric extracorporeal membrane oxygenation circuits. ASAIO J 68:133\u2013152. https:\/\/doi.org\/10.1097\/MAT.0000000000001630","journal-title":"ASAIO J"},{"key":"408_CR12","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1001\/jama.2021.18323","volume":"326","author":"MD Samsky","year":"2021","unstructured":"Samsky MD, Morrow DA, Proudfoot AG, Hochman JS, Thiele H, Rao SV (2021) Cardiogenic shock after acute myocardial infarction: a review. JAMA 326:1840. https:\/\/doi.org\/10.1001\/jama.2021.18323","journal-title":"JAMA"},{"key":"408_CR13","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/ejhf.260","volume":"17","author":"V Harjola","year":"2015","unstructured":"Harjola V, Lassus J, Sionis A, K\u00f8ber L, Tarvasm\u00e4ki T, Spinar J et al (2015) Clinical picture and risk prediction of short\u2010term mortality in cardiogenic shock. Eur J Heart Fail 17:501\u2013509. https:\/\/doi.org\/10.1002\/ejhf.260","journal-title":"Eur J Heart Fail"},{"key":"408_CR14","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.healun.2023.09.014","volume":"43","author":"MK Kanwar","year":"2024","unstructured":"Kanwar MK, Billia F, Randhawa V, Cowger JA, Barnett CM, Chih S et al (2024) Heart failure related cardiogenic shock: an ISHLT consensus conference content summary. J Heart Lung Transplant 43:189\u2013203. https:\/\/doi.org\/10.1016\/j.healun.2023.09.014","journal-title":"J Heart Lung Transplant"},{"key":"408_CR15","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1002\/ejhf.3531","volume":"27","author":"V Galusko","year":"2025","unstructured":"Galusko V, Wenzl FA, Vandenbriele C, Panoulas V, L\u00fcscher TF, Gorog DA (2025) Current and novel biomarkers in cardiogenic shock. Eur J Heart Fail 27:1106\u20131125. https:\/\/doi.org\/10.1002\/ejhf.3531","journal-title":"Eur J Heart Fail"},{"key":"408_CR16","doi-asserted-by":"publisher","unstructured":"Elmadhoun O, Karadzha A, Kor NT, Almadhoun H, Ortoleva JP, Ripoll JG et al (2025) Biomarkers in cardiogenic shock: from bench to bedside. J Cardiothorac Vasc Anesth S1053077025011449. https:\/\/doi.org\/10.1053\/j.jvca.2025.11.015","DOI":"10.1053\/j.jvca.2025.11.015"},{"key":"408_CR17","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1161\/01.CIR.92.8.2198","volume":"92","author":"JM Hare","year":"1995","unstructured":"Hare JM, Loh E, Creager MA, Colucci WS (1995) Nitric oxide inhibits the positive inotropic response to \u03b2-adrenergic stimulation in humans with left ventricular dysfunction. Circulation 92:2198\u20132203. https:\/\/doi.org\/10.1161\/01.CIR.92.8.2198","journal-title":"Circulation"},{"key":"408_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2024.101432","volume":"4","author":"JC Jentzer","year":"2024","unstructured":"Jentzer JC, Berg DD, Chonde MD, Dahiya G, Elliott A, Rampersad P et al (2024) Mixed cardiogenic-vasodilatory shock. JACC. Advances 4:101432. https:\/\/doi.org\/10.1016\/j.jacadv.2024.101432","journal-title":"Advances"},{"key":"408_CR19","doi-asserted-by":"publisher","DOI":"10.1097\/CCE.0000000000001361","volume":"7","author":"PM Wieruszewski","year":"2025","unstructured":"Wieruszewski PM, Ortoleva JP, Bauer SR, Ripoll JG, Chatterjee S, Gerberi DJ et al (2025) Definitions for vasoplegia associated with on-pump cardiac surgery: a systematic review with meta-analysis. Crit Care Explor 7:e1361. https:\/\/doi.org\/10.1097\/CCE.0000000000001361","journal-title":"Crit Care Explor"},{"key":"408_CR20","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jointm.2021.11.004","volume":"2","author":"F Boissier","year":"2022","unstructured":"Boissier F, Aissaoui N (2022) Septic cardiomyopathy: diagnosis and management. J Intensive Med 2:8\u201316. https:\/\/doi.org\/10.1016\/j.jointm.2021.11.004","journal-title":"J Intensive Med"},{"key":"408_CR21","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41569-020-00492-2","volume":"18","author":"SM Hollenberg","year":"2021","unstructured":"Hollenberg SM, Singer M (2021) Pathophysiology of sepsis-induced cardiomyopathy. Nat Rev Cardiol 18:424\u2013434. https:\/\/doi.org\/10.1038\/s41569-020-00492-2","journal-title":"Nat Rev Cardiol"},{"key":"408_CR22","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1007\/s12265-025-10647-6","volume":"18","author":"OK H\u00f8rsdal","year":"2025","unstructured":"H\u00f8rsdal OK, Frederiksen PH, Helgestad OKL, Ravn HB, M\u00f8ller JE, Wiggers H et al (2025) The immediate cardiovascular and mitochondrial response in ischemic cardiogenic shock. J Cardiovasc Transl Res 18:1204\u20131217. https:\/\/doi.org\/10.1007\/s12265-025-10647-6","journal-title":"J Cardiovasc Transl Res"},{"key":"408_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-016-1570-4","volume":"20","author":"JE Millar","year":"2016","unstructured":"Millar JE, Fanning JP, McDonald CI, McAuley DF, Fraser JF (2016) The inflammatory response to extracorporeal membrane oxygenation (ECMO): a review of the pathophysiology. Crit Care 20:387. https:\/\/doi.org\/10.1186\/s13054-016-1570-4","journal-title":"Crit Care"},{"key":"408_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s40635-019-0249-y","volume":"7","author":"A Al-Fares","year":"2019","unstructured":"Al-Fares A, Pettenuzzo T, Del Sorbo L (2019) Extracorporeal life support and systemic inflammation. Intensive Care Med Exp 7:46. https:\/\/doi.org\/10.1186\/s40635-019-0249-y","journal-title":"Intensive Care Med Exp"},{"key":"408_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.831930","volume":"13","author":"S Hatami","year":"2022","unstructured":"Hatami S, Hefler J, Freed DH (2022) Inflammation and oxidative stress in the context of extracorporeal cardiac and pulmonary support. Front Immunol 13:831930. https:\/\/doi.org\/10.3389\/fimmu.2022.831930","journal-title":"Front Immunol"},{"key":"408_CR26","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.cardfail.2024.07.015","volume":"30","author":"S Gorgis","year":"2024","unstructured":"Gorgis S, Gupta K, Lemor A, Bentley D, Moyer C, McRAE T et al (2024) Impact of right ventricular dysfunction on outcomes in acute myocardial infarction and cardiogenic shock: insights from the National Cardiogenic Shock Initiative. J Card Fail 30:1275\u20131284. https:\/\/doi.org\/10.1016\/j.cardfail.2024.07.015","journal-title":"J Card Fail"},{"key":"408_CR27","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1093\/eurheartj\/ehaf215","volume":"46","author":"G Giannakoulas","year":"2025","unstructured":"Giannakoulas G, Farmakis IT, Hobohm L, Verbrugge FH, Tedford RJ, Sanz J (2025) Acute right ventricular failure: pathophysiology, aetiology, assessment, and management. Eur Heart J 46:2520\u20132535. https:\/\/doi.org\/10.1093\/eurheartj\/ehaf215","journal-title":"Eur Heart J"},{"key":"408_CR28","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.031401","volume":"12","author":"MB Basir","year":"2023","unstructured":"Basir MB, Lemor A, Gorgis S, Patel KC, Kolski BC, Bharadwaj AS et al (2023) Early utilization of mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock: the National Cardiogenic Shock Initiative. J Am Heart Assoc 12:e031401. https:\/\/doi.org\/10.1161\/JAHA.123.031401","journal-title":"J Am Heart Assoc"},{"key":"408_CR29","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1053\/j.jvca.2024.12.007","volume":"39","author":"JS Saggu","year":"2025","unstructured":"Saggu JS, Seelhammer TG, Esmaeilzadeh S, Roberts JA, Radosevich MA, Ripoll JG et al (2025) Mechanical circulatory support for acute myocardial infarction cardiogenic shock: review and recent updates. J Cardiothorac Vasc Anesth 39:1049\u20131066. https:\/\/doi.org\/10.1053\/j.jvca.2024.12.007","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"408_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0223604","volume":"14","author":"TS Mu","year":"2019","unstructured":"Mu TS, Becker AM, Clark AJ, Batts SG, Murata L-AM, Uyehara CFT (2019) ECMO with vasopressor use during early endotoxic shock: can it improve circulatory support and regional microcirculatory blood flow? PLoS ONE 14:e0223604. https:\/\/doi.org\/10.1371\/journal.pone.0223604","journal-title":"PLoS ONE"},{"key":"408_CR31","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1007\/s00134-024-07645-8","volume":"50","author":"J Badulak","year":"2024","unstructured":"Badulak J, Abrams D, Luks AM, Zakhary B, Conrad SA, Bartlett R et al (2024) Position paper on the physiology and nomenclature of dual circulation during venoarterial ECMO in adults. Intensive Care Med 50:1994\u20132004. https:\/\/doi.org\/10.1007\/s00134-024-07645-8","journal-title":"Intensive Care Med"},{"key":"408_CR32","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s11886-024-02067-w","volume":"26","author":"I Protti","year":"2024","unstructured":"Protti I, Van Steenwijk MPJ, Meani P, Fresiello L, Meuwese CL, Donker DW (2024) Left ventricular unloading in extracorporeal membrane oxygenation: a clinical perspective derived from basic cardiovascular physiology. Curr Cardiol Rep 26:661\u2013667. https:\/\/doi.org\/10.1007\/s11886-024-02067-w","journal-title":"Curr Cardiol Rep"},{"key":"408_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12186069","volume":"12","author":"J Soltes","year":"2023","unstructured":"Soltes J, Rob D, Kavalkova P, Bruthans J, Belohlavek J (2023) Growing evidence for LV unloading in VA ECMO. J Clin Med 12:6069. https:\/\/doi.org\/10.3390\/jcm12186069","journal-title":"J Clin Med"},{"key":"408_CR34","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1177\/0267659118794112","volume":"34","author":"DW Donker","year":"2019","unstructured":"Donker DW, Brodie D, Henriques JPS, Broom\u00e9 M (2019) Left ventricular unloading during veno-arterial ECMO: a review of percutaneous and surgical unloading interventions. Perfusion 34:98\u2013105. https:\/\/doi.org\/10.1177\/0267659118794112","journal-title":"Perfusion"},{"key":"408_CR35","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1097\/MCC.0000000000000837","volume":"27","author":"D Rob","year":"2021","unstructured":"Rob D, B\u011blohl\u00e1vek J (2021) The mechanical support of cardiogenic shock. Curr Opin Crit Care 27:440\u2013446. https:\/\/doi.org\/10.1097\/MCC.0000000000000837","journal-title":"Curr Opin Crit Care"},{"key":"408_CR36","doi-asserted-by":"publisher","unstructured":"Ortuno S, Delmas C, Diehl J-L, Bailleul C, Lancelot A, Naili M et al (2019) Weaning from veno-arterial extra-corporeal membrane oxygenation: which strategy to use? Ann Cardiothorac Surg 8:E1\u20138. https:\/\/doi.org\/10.21037\/acs.2018.08.05","DOI":"10.21037\/acs.2018.08.05"},{"key":"408_CR37","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1093\/ehjacc\/zuad064","volume":"12","author":"JE M\u00f8ller","year":"2023","unstructured":"M\u00f8ller JE, Sionis A, Aissaoui N, Ariza A, B\u011blohl\u00e1vek J, De Backer D et al (2023) Step by step daily management of short-term mechanical circulatory support for cardiogenic shock in adults in the intensive cardiac care unit: a clinical consensus statement of the Association for Acute CardioVascular Care of the European Society of Cardiology SC, the European Society of Intensive Care Medicine, the European branch of the Extracorporeal Life Support Organization, and the European Association for Cardio-Thoracic Surgery. Eur Heart J Acute Cardiovasc Care 12:475\u2013485. https:\/\/doi.org\/10.1093\/ehjacc\/zuad064","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"408_CR38","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1186\/s13054-022-04249-w","volume":"26","author":"F Charbonneau","year":"2022","unstructured":"Charbonneau F, Chahinian K, Bebawi E, Lavigueur O, L\u00e9vesque \u00c9, Lamarche Y et al (2022) Parameters associated with successful weaning of veno-arterial extracorporeal membrane oxygenation: a systematic review. Crit Care 26:375. https:\/\/doi.org\/10.1186\/s13054-022-04249-w","journal-title":"Crit Care"},{"key":"408_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-022-03911-7","volume":"26","author":"PM Wieruszewski","year":"2022","unstructured":"Wieruszewski PM, Khanna AK (2022) Vasopressor choice and timing in vasodilatory shock. Crit Care 26:76. https:\/\/doi.org\/10.1186\/s13054-022-03911-7","journal-title":"Crit Care"},{"key":"408_CR40","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ando.2020.03.012","volume":"82","author":"J Motiejunaite","year":"2021","unstructured":"Motiejunaite J, Amar L, Vidal-Petiot E (2021) Adrenergic receptors and cardiovascular effects of catecholamines. Annales d\u2019Endocrinologie 82:193\u2013197. https:\/\/doi.org\/10.1016\/j.ando.2020.03.012","journal-title":"Annales d\u2019Endocrinologie"},{"key":"408_CR41","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1007\/s00134-019-05801-z","volume":"45","author":"JA Russell","year":"2019","unstructured":"Russell JA (2019) Vasopressor therapy in critically ill patients with shock. Intensive Care Med 45:1503\u20131517. https:\/\/doi.org\/10.1007\/s00134-019-05801-z","journal-title":"Intensive Care Med"},{"key":"408_CR42","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1177\/0885066609340519","volume":"24","author":"MW D\u00fcnser","year":"2009","unstructured":"D\u00fcnser MW, Hasibeder WR (2009) Sympathetic overstimulation during critical illness: adverse effects of adrenergic stress. J Intensive Care Med 24:293\u2013316. https:\/\/doi.org\/10.1177\/0885066609340519","journal-title":"J Intensive Care Med"},{"key":"408_CR43","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1053\/j.jvca.2024.04.010","volume":"38","author":"Y Kotani","year":"2024","unstructured":"Kotani Y, D\u2019Andria Ursoleo J, Murru CP, Landoni G (2024) Blood pressure management for hypotensive patients in intensive care and perioperative cardiovascular settings. J Cardiothorac Vasc Anesth 38:2089\u20132099. https:\/\/doi.org\/10.1053\/j.jvca.2024.04.010","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"408_CR44","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/0163-7258(93)90030-H","volume":"60","author":"O-E Brodde","year":"1993","unstructured":"Brodde O-E (1993) Beta-adrenoceptors in cardiac disease. Pharmacol Ther 60:405\u2013430. https:\/\/doi.org\/10.1016\/0163-7258(93)90030-H","journal-title":"Pharmacol Ther"},{"key":"408_CR45","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1056\/NEJM198409273111303","volume":"311","author":"JN Cohn","year":"1984","unstructured":"Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS et al (1984) Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 311:819\u2013823. https:\/\/doi.org\/10.1056\/NEJM198409273111303","journal-title":"N Engl J Med"},{"key":"408_CR46","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1097\/ALN.0000000000004593","volume":"139","author":"MR Mathis","year":"2023","unstructured":"Mathis MR, Janda AM, Kheterpal S, Schonberger RB, Pagani FD, Engoren MC et al (2023) Patient-, clinician-, and institution-level variation in inotrope use for cardiac surgery: a multicenter observational analysis. Anesthesiology 139:122\u2013141. https:\/\/doi.org\/10.1097\/ALN.0000000000004593","journal-title":"Anesthesiology"},{"key":"408_CR47","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1186\/s13054-019-2605-4","volume":"23","author":"V Zotzmann","year":"2019","unstructured":"Zotzmann V, Rilinger J, Lang CN, Kaier K, Benk C, Duerschmied D et al (2019) Epinephrine, inodilator, or no inotrope in venoarterial extracorporeal membrane oxygenation implantation: a single-center experience. Crit Care 23:320. https:\/\/doi.org\/10.1186\/s13054-019-2605-4","journal-title":"Crit Care"},{"key":"408_CR48","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1002\/ehf2.13370","volume":"8","author":"N Massart","year":"2021","unstructured":"Massart N, Mansour A, Ross JT, Ecoffey C, Aninat C, Verhoye J et al (2021) Epinephrine administration in venoarterial extracorporeal membrane oxygenation patients is associated with mortality: a retrospective cohort study. ESC Heart Failure 8:2899\u20132906. https:\/\/doi.org\/10.1002\/ehf2.13370","journal-title":"ESC Heart Failure"},{"key":"408_CR49","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ajem.2024.03.013","volume":"80","author":"SI Garcia","year":"2024","unstructured":"Garcia SI, Seelhammer TG, Saddoughi SA, Finch AS, Park JG, Wieruszewski PM (2024) Cumulative epinephrine dose during cardiac arrest and neurologic outcome after extracorporeal cardiopulmonary resuscitation. Am J Emerg Med 80:61\u201366. https:\/\/doi.org\/10.1016\/j.ajem.2024.03.013","journal-title":"Am J Emerg Med"},{"key":"408_CR50","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1007\/s00134-008-1219-0","volume":"34","author":"JA Myburgh","year":"2008","unstructured":"Myburgh JA, Higgins A, Jovanovska A, Lipman J, Ramakrishnan N, Santamaria J (2008) A comparison of epinephrine and norepinephrine in critically ill patients. Intensive Care Med 34:2226\u20132234. https:\/\/doi.org\/10.1007\/s00134-008-1219-0","journal-title":"Intensive Care Med"},{"key":"408_CR51","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.resuscitation.2020.10.001","volume":"159","author":"M McLure","year":"2021","unstructured":"McLure M, Eastwood K, Parr M, Bray J (2021) A rapid review of advanced life support guidelines for cardiac arrest associated with anaphylaxis. Resuscitation 159:137\u2013149. https:\/\/doi.org\/10.1016\/j.resuscitation.2020.10.001","journal-title":"Resuscitation"},{"key":"408_CR52","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1056\/NEJMoa0907118","volume":"362","author":"D De Backer","year":"2010","unstructured":"De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C et al (2010) Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 362:779\u2013789. https:\/\/doi.org\/10.1056\/NEJMoa0907118","journal-title":"N Engl J Med"},{"key":"408_CR53","doi-asserted-by":"publisher","unstructured":"Van Diepen S, Katz JN, Albert NM, Henry TD, Jacobs AK, Kapur NK et al (2017) Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association. Circulation 136. https:\/\/doi.org\/10.1161\/CIR.0000000000000525. Cited 2026 Jan 4","DOI":"10.1161\/CIR.0000000000000525"},{"key":"408_CR54","doi-asserted-by":"publisher","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","volume":"49","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C et al (2021) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med 49:e1063\u2013e1143. https:\/\/doi.org\/10.1097\/CCM.0000000000005337","journal-title":"Crit Care Med"},{"key":"408_CR55","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1053\/j.jvca.2020.11.032","volume":"35","author":"F Guarracino","year":"2021","unstructured":"Guarracino F, Habicher M, Treskatsch S, Sander M, Szekely A, Paternoster G et al (2021) Vasopressor therapy in cardiac surgery-an experts\u2019 consensus statement. J Cardiothorac Vasc Anesth 35:1018\u20131029. https:\/\/doi.org\/10.1053\/j.jvca.2020.11.032","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"408_CR56","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1097\/CCM.0000000000006176","volume":"52","author":"PM Wieruszewski","year":"2024","unstructured":"Wieruszewski PM, Leone M, Kaas-Hansen BS, Dugar S, Legrand M, McKenzie CA et al (2024) Position paper on the reporting of norepinephrine formulations in critical care from the Society of Critical Care Medicine and European Society of Intensive Care Medicine Joint Task Force. Crit Care Med 52:521\u2013530. https:\/\/doi.org\/10.1097\/CCM.0000000000006176","journal-title":"Crit Care Med"},{"key":"408_CR57","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1007\/s00134-025-08053-2","volume":"51","author":"J D\u2019Andria Ursoleo","year":"2025","unstructured":"D\u2019Andria Ursoleo J, Bottussi A, Khanna AK, Leone M, Wieruszewski PM, Monaco F (2025) Norepinephrine pharmacolexicology: a chronological review of dose reporting and the implications of salt formulations. Intensive Care Med 51:1664\u20131673. https:\/\/doi.org\/10.1007\/s00134-025-08053-2","journal-title":"Intensive Care Med"},{"key":"408_CR58","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1177\/0885066620918776","volume":"36","author":"JC Jentzer","year":"2021","unstructured":"Jentzer JC, Ternus B, Eleid M, Rihal C (2021) Structural heart disease emergencies. J Intensive Care Med 36:975\u2013988. https:\/\/doi.org\/10.1177\/0885066620918776","journal-title":"J Intensive Care Med"},{"key":"408_CR59","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1186\/s13054-024-05016-9","volume":"28","author":"FG Zampieri","year":"2024","unstructured":"Zampieri FG, Bagshaw SM, Njimi H, Vincent J-L, DeBacker D, SOAP II Investigators et al (2024) Exploration of different statistical approaches in the comparison of dopamine and norepinephrine in the treatment of shock: SOAP II. Crit Care 28:299. https:\/\/doi.org\/10.1186\/s13054-024-05016-9","journal-title":"Crit Care"},{"key":"408_CR60","doi-asserted-by":"publisher","first-page":"3711","DOI":"10.1111\/jocs.15861","volume":"36","author":"JY Lim","year":"2021","unstructured":"Lim JY, Park SJ, Kim HJ, Kim HJ, Choo SJ, Chung CH et al (2021) Comparison of dopamine versus norepinephrine in circulatory shock after cardiac surgery: a randomized controlled trial. J Card Surg 36:3711\u20133718. https:\/\/doi.org\/10.1111\/jocs.15861","journal-title":"J Card Surg"},{"key":"408_CR61","doi-asserted-by":"publisher","unstructured":"Fordyce CB, Katz JN, Alviar CL, Arslanian-Engoren C, Bohula EA, Geller BJ et al (2020) Prevention of complications in the cardiac intensive care unit: a scientific statement from the American Heart Association. Circulation 142. https:\/\/doi.org\/10.1161\/CIR.0000000000000909. Cited 2026 Jan 4","DOI":"10.1161\/CIR.0000000000000909"},{"key":"408_CR62","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1056\/NEJMoa2026845","volume":"385","author":"R Mathew","year":"2021","unstructured":"Mathew R, Di Santo P, Jung RG, Marbach JA, Hutson J, Simard T et al (2021) Milrinone as compared with dobutamine in the treatment of cardiogenic shock. N Engl J Med 385:516\u2013525. https:\/\/doi.org\/10.1056\/NEJMoa2026845","journal-title":"N Engl J Med"},{"key":"408_CR63","doi-asserted-by":"publisher","DOI":"10.1097\/CCE.0000000000000962","volume":"5","author":"O Abdel-Razek","year":"2023","unstructured":"Abdel-Razek O, Di Santo P, Jung RG, Parlow S, Motazedian P, Prosperi-Porta G et al (2023) Efficacy of milrinone and dobutamine in cardiogenic shock: an updated systematic review and meta-analysis. Crit Care Explor 5:e0962. https:\/\/doi.org\/10.1097\/CCE.0000000000000962","journal-title":"Crit Care Explor"},{"key":"408_CR64","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1159\/000499400","volume":"142","author":"S Kobayashi","year":"2019","unstructured":"Kobayashi S, Myoren T, Kajii T, Kohno M, Nanno T, Ishiguchi H et al (2019) Addition of a \u03b21-blocker to milrinone treatment improves cardiac function in patients with acute heart failure and rapid atrial fibrillation. Cardiology 142:195\u2013202. https:\/\/doi.org\/10.1159\/000499400","journal-title":"Cardiology"},{"key":"408_CR65","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1136\/hrt.38.6.622","volume":"38","author":"F Kersting","year":"1976","unstructured":"Kersting F, Follath F, Moulds R, Mucklow J, McCloy R, Sheares J et al (1976) A comparison of cardiovascular effects of dobutamine and isoprenaline after open heart surgery. Br Heart J 38:622\u2013626. https:\/\/doi.org\/10.1136\/hrt.38.6.622","journal-title":"Br Heart J"},{"key":"408_CR66","doi-asserted-by":"publisher","unstructured":"Worthley LIG, Tyler P, Moran JL (1985) A comparison of dopamine, dobutamine and isoproterenol in the treatment of shock. Intensive Care Med 11. https:\/\/doi.org\/10.1007\/BF00256059. Cited 2026 Jan 7","DOI":"10.1007\/BF00256059"},{"key":"408_CR67","doi-asserted-by":"publisher","first-page":"H131","DOI":"10.1152\/ajpheart.00200.2024","volume":"327","author":"D Levy","year":"2024","unstructured":"Levy D, Saura O, Lucenteforte M, Collado Lled\u00f3 E, Demondion P, Hammoudi N et al (2024) Isoproterenol improves hemodynamics and right ventricle-pulmonary artery coupling after heart transplantation. Am J Physiol Heart Circ Physiol 327:H131\u2013H137. https:\/\/doi.org\/10.1152\/ajpheart.00200.2024","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"408_CR68","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1172\/JCI106408","volume":"49","author":"H Mueller","year":"1970","unstructured":"Mueller H, Ayres SM, Gregory JJ, Giannelli S, Grace WJ (1970) Hemodynamics, coronary blood flow, and myocardial metabolism in coronary shock; response to l-norepinephrine and isoproterenol. J Clin Invest 49:1885\u20131902. https:\/\/doi.org\/10.1172\/JCI106408","journal-title":"J Clin Invest"},{"key":"408_CR69","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1161\/01.CIR.43.1.67","volume":"43","author":"PR Maroko","year":"1971","unstructured":"Maroko PR, Kjekshus JK, Sobel BE, Watanabe T, Covell JW, Ross J et al (1971) Factors influencing infarct size following experimental coronary artery occlusions. Circulation 43:67\u201382. https:\/\/doi.org\/10.1161\/01.CIR.43.1.67","journal-title":"Circulation"},{"key":"408_CR70","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/cc8224","volume":"15","author":"JA Russell","year":"2009","unstructured":"Russell JA (2009) Bench-to-bedside review: vasopressin in the management of septic shock. Crit Care 15:226. https:\/\/doi.org\/10.1186\/cc8224","journal-title":"Crit Care"},{"key":"408_CR71","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1161\/01.CIR.95.5.1122","volume":"95","author":"DW Landry","year":"1997","unstructured":"Landry DW, Levin HR, Gallant EM, Ashton RC, Seo S, D\u2019Alessandro D et al (1997) Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 95:1122\u20131125. https:\/\/doi.org\/10.1161\/01.CIR.95.5.1122","journal-title":"Circulation"},{"key":"408_CR72","doi-asserted-by":"publisher","unstructured":"Leone M, Khanna AK, Wieruszewski PM (2025) Mastering the practical application of vasopressin at the bedside in septic shock. Intensive Care Med. https:\/\/doi.org\/10.1007\/s00134-025-08204-5. Cited 2025 Dec 29","DOI":"10.1007\/s00134-025-08204-5"},{"key":"408_CR73","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1097\/ALN.0000000000000430","volume":"121","author":"DA Currigan","year":"2014","unstructured":"Currigan DA, Hughes RJA, Wright CE, Angus JA, Soeding PF (2014) Vasoconstrictor responses to vasopressor agents in human pulmonary and radial arteries: an in vitro study. Anesthesiology 121:930\u2013936. https:\/\/doi.org\/10.1097\/ALN.0000000000000430","journal-title":"Anesthesiology"},{"key":"408_CR74","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1510\/icvts.2007.159624","volume":"6","author":"E Tayama","year":"2007","unstructured":"Tayama E, Ueda T, Shojima T, Akasu K, Oda T, Fukunaga S et al (2007) Arginine vasopressin is an ideal drug after cardiac surgery for the management of low systemic vascular resistant hypotension concomitant with pulmonary hypertension. Interact Cardiovasc Thorac Surg 6:715\u2013719. https:\/\/doi.org\/10.1510\/icvts.2007.159624","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"408_CR75","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1001\/jama.2018.4528","volume":"319","author":"WF McIntyre","year":"2018","unstructured":"McIntyre WF, Um KJ, Alhazzani W, Lengyel AP, Hajjar L, Gordon AC et al (2018) Association of vasopressin plus catecholamine vasopressors vs catecholamines alone with atrial fibrillation in patients with distributive shock: a systematic review and meta-analysis. JAMA 319:1889. https:\/\/doi.org\/10.1001\/jama.2018.4528","journal-title":"JAMA"},{"key":"408_CR76","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1097\/shk.0000000000002558","volume":"63","author":"SR Bauer","year":"2025","unstructured":"Bauer SR, Wieruszewski PM, Bissell Turpin BD, Dugar S, Sacha GL, Sato R et al (2025) Adjunctive vasopressors and short-term mortality in adults with septic shock: a systematic review and meta-analysis. Shock 63:668\u2013676. https:\/\/doi.org\/10.1097\/shk.0000000000002558","journal-title":"Shock"},{"key":"408_CR77","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-024-05212-7","volume":"28","author":"Y Kotani","year":"2024","unstructured":"Kotani Y, Belletti A, D\u2019Amico F, Bonaccorso A, Wieruszewski PM, Fujii T et al (2024) Non-adrenergic vasopressors for vasodilatory shock or perioperative vasoplegia: a meta-analysis of randomized controlled trials. Crit Care 28:439. https:\/\/doi.org\/10.1186\/s13054-024-05212-7","journal-title":"Crit Care"},{"key":"408_CR78","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1097\/CCM.0000000000005317","volume":"50","author":"GL Sacha","year":"2022","unstructured":"Sacha GL, Lam SW, Wang L, Duggal A, Reddy AJ, Bauer SR (2022) Association of catecholamine dose, lactate, and shock duration at vasopressin initiation with mortality in patients with septic shock. Crit Care Med 50:614\u2013623. https:\/\/doi.org\/10.1097\/CCM.0000000000005317","journal-title":"Crit Care Med"},{"key":"408_CR79","volume":"7","author":"GL Sacha","year":"2025","unstructured":"Sacha GL, Duggal A, Reddy AJ, Wang L, Bauer SR (2025) Vasopressin initiation timing and in-hospital mortality in septic shock: an observational study of large public databases. Crit Care Explor 7:e1284","journal-title":"Crit Care Explor"},{"key":"408_CR80","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.ccrj.2024.09.002","volume":"26","author":"KC White","year":"2024","unstructured":"White KC, Costa-Pinto R, Chaba A, McIlroy P, Senthuran S, Luke S et al (2024) Timing of adjunctive vasopressin initiation for septic shock patients and hospital mortality: a multicentre observational study. Crit Care Resusc 26:295\u2013302. https:\/\/doi.org\/10.1016\/j.ccrj.2024.09.002","journal-title":"Crit Care Resusc"},{"key":"408_CR81","doi-asserted-by":"publisher","unstructured":"Guinot PG, Nguyen M, Berthoud V, Abou-Arab O, Bouhemad B, Beyls C, VASO-SHOCK group study (2026) Timing of vasopressin initiation influences renal outcomes in mixed cardiogenic-vasodilatory shock supported by VA-ECMO. Anaesth Crit Care Pain Med 45(3):101670. https:\/\/doi.org\/10.1016\/j.accpm.2025.101670. Epub 2025 Nov 7. PMID: 41207377","DOI":"10.1016\/j.accpm.2025.101670"},{"key":"408_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.accpm.2023.101193","volume":"42","author":"M Leone","year":"2023","unstructured":"Leone M, Einav S, Antonucci E, Depret F, Lakbar I, Martin-Loeches I et al (2023) Multimodal strategy to counteract vasodilation in septic shock. Anaesth Crit Care Pain Med 42:101193. https:\/\/doi.org\/10.1016\/j.accpm.2023.101193","journal-title":"Anaesth Crit Care Pain Med"},{"key":"408_CR83","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-018-2202-y","volume":"22","author":"LS Chawla","year":"2018","unstructured":"Chawla LS, Chen S, Bellomo R, Tidmarsh GF (2018) Angiotensin converting enzyme defects in shock: implications for future therapy. Crit Care 22:274. https:\/\/doi.org\/10.1186\/s13054-018-2202-y","journal-title":"Crit Care"},{"key":"408_CR84","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1186\/s13054-025-05577-3","volume":"29","author":"C Strik-Lips","year":"2025","unstructured":"Strik-Lips C, Van Lier D, Van Herwaarden AE, Frenzel T, Pickkers P (2025) Effects of Angiotensin 2 infusion on the RAAS and alternative RAAS pathway. Crit Care 29:369. https:\/\/doi.org\/10.1186\/s13054-025-05577-3","journal-title":"Crit Care"},{"key":"408_CR85","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1164\/rccm.201911-2172OC","volume":"202","author":"R Bellomo","year":"2020","unstructured":"Bellomo R, Forni LG, Busse LW, McCurdy MT, Ham KR, Boldt DW et al (2020) Renin and survival in patients given Angiotensin II for catecholamine-resistant vasodilatory shock. A clinical trial. Am J Respir Crit Care Med 202:1253\u20131261. https:\/\/doi.org\/10.1164\/rccm.201911-2172OC","journal-title":"Am J Respir Crit Care Med"},{"key":"408_CR86","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s13054-023-04446-1","volume":"27","author":"PM Wieruszewski","year":"2023","unstructured":"Wieruszewski PM, Bellomo R, Busse LW, Ham KR, Zarbock A, Khanna AK et al (2023) Initiating Angiotensin II at lower vasopressor doses in vasodilatory shock: an exploratory post-hoc analysis of the ATHOS-3 clinical trial. Crit Care 27:175. https:\/\/doi.org\/10.1186\/s13054-023-04446-1","journal-title":"Crit Care"},{"key":"408_CR87","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1053\/j.jvca.2022.01.002","volume":"36","author":"A Mohamed","year":"2022","unstructured":"Mohamed A, Berry TP, Welge JA, Thomas EL, Zhurav L, Kozinn J et al (2022) Angiotensin II in patients with shock on mechanical circulatory support: a single-center retrospective case series. J Cardiothorac Vasc Anesth 36:2439\u20132445. https:\/\/doi.org\/10.1053\/j.jvca.2022.01.002","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"408_CR88","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1177\/08850666221145864","volume":"38","author":"PM Wieruszewski","year":"2023","unstructured":"Wieruszewski PM, Seelhammer TG, Barreto EF, Busse LW, Chow JH, Davison DL et al (2023) Angiotensin II for vasodilatory hypotension in patients requiring mechanical circulatory support. J Intensive Care Med 38:464\u2013471. https:\/\/doi.org\/10.1177\/08850666221145864","journal-title":"J Intensive Care Med"},{"key":"408_CR89","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.1053\/j.jvca.2024.09.148","volume":"38","author":"J Lim","year":"2024","unstructured":"Lim J, Zhang K, Miles L, Bellomo R, Coulson TG (2024) The effects of Angiotensin II versus Norepinephrine on pulmonary vascular resistance in cardiac surgery: post hoc analysis of a randomized controlled trial. J Cardiothorac Vasc Anesth 38:2950\u20132958. https:\/\/doi.org\/10.1053\/j.jvca.2024.09.148","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"408_CR90","doi-asserted-by":"publisher","first-page":"4958","DOI":"10.3390\/jcm11174958","volume":"11","author":"M Kim","year":"2022","unstructured":"Kim M, Seong S-W, Song PS, Jeong J-O, Yang JH, Gwon H-C et al (2022) Inodilators may improve the in-hospital mortality of patients with cardiogenic shock undergoing veno-arterial extracorporeal membrane oxygenation. J Clin Med 11:4958. https:\/\/doi.org\/10.3390\/jcm11174958","journal-title":"J Clin Med"},{"key":"408_CR91","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/0002-9149(87)90616-3","volume":"60","author":"EJ Eichhorn","year":"1987","unstructured":"Eichhorn EJ, Konstam MA, Weiland DS, Roberts DJ, Martin TT, Stransky NB et al (1987) Differential effects of Milrinone and Dobutamine on right ventricular preload, afterload and systolic performance in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 60:1329\u20131333. https:\/\/doi.org\/10.1016\/0002-9149(87)90616-3","journal-title":"Am J Cardiol"},{"key":"408_CR92","doi-asserted-by":"publisher","unstructured":"Whelan AJ, Mim S, Hunt JP, McKnite AM, Green DJ, Imburgia CE et al (2024) Interaction of Milrinone with extracorporeal life support. J Extra Corpor Technol 56:167\u2013173. https:\/\/doi.org\/10.1051\/ject\/2024014","DOI":"10.1051\/ject\/2024014"},{"key":"408_CR93","doi-asserted-by":"publisher","unstructured":"Bertin S, Guidi M, Haefliger D, Thoueille P, Bardinet C, Decosterd LA et al (2025) Population pharmacokinetics of Levosimendan and its metabolites OR-1855 and OR-1896 in critically ill adults, neonates and infants on veno-arterial ECMO. Clin Pharmacokinet. https:\/\/doi.org\/10.1007\/s40262-025-01591-4","DOI":"10.1007\/s40262-025-01591-4"},{"key":"408_CR94","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-023-04328-6","volume":"27","author":"J Massol","year":"2023","unstructured":"Massol J, Simon-Tillaux N, Tohme J, Hariri G, Dureau P, Duceau B et al (2023) Levosimendan in patients undergoing extracorporeal membrane oxygenation after cardiac surgery: an emulated target trial using observational data. Crit Care 27:51. https:\/\/doi.org\/10.1186\/s13054-023-04328-6","journal-title":"Crit Care"},{"key":"408_CR95","doi-asserted-by":"publisher","unstructured":"Combes A, Saura O, Nesseler N, Lebbah S, Rozec B, Levy B et al (2025) Levosimendan to facilitate weaning from ECMO in patients with severe cardiogenic shock: the LEVOECMO randomized clinical trial. JAMA. https:\/\/doi.org\/10.1001\/jama.2025.19843. Cited 2026 Jan 5","DOI":"10.1001\/jama.2025.19843"},{"key":"408_CR96","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1111\/aor.14540","volume":"47","author":"C Gaisendrees","year":"2023","unstructured":"Gaisendrees C, Schlachtenberger G, Gerfer S, Krasivskyi I, Djordjevic I, Sabashnikov A et al (2023) The impact of levosimendan on survival and weaning from ECMO after extracorporeal cardiopulmonary resuscitation. Artif Organs 47:1351\u20131360. https:\/\/doi.org\/10.1111\/aor.14540","journal-title":"Artif Organs"},{"key":"408_CR97","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.912321","volume":"9","author":"Y-W Chen","year":"2022","unstructured":"Chen Y-W, Lee W-C, Wu P-J, Fang H-Y, Fang Y-N, Chen H-C et al (2022) Early levosimendan administration improved weaning success rate in extracorporeal membrane oxygenation in patients with cardiogenic shock. Front Cardiovasc Med 9:912321. https:\/\/doi.org\/10.3389\/fcvm.2022.912321","journal-title":"Front Cardiovasc Med"},{"key":"408_CR98","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2025-101995","volume":"15","author":"G Zhao","year":"2025","unstructured":"Zhao G, Zhao G, Zhang H, Chen W, Zhou J-X, Li H (2025) Clinical outcomes of levosimendan administration in veno-arterial extracorporeal membrane oxygenation: a meta-analysis. BMJ Open 15:e101995. https:\/\/doi.org\/10.1136\/bmjopen-2025-101995","journal-title":"BMJ Open"}],"container-title":["Journal of Anesthesia, Analgesia and Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s44158-026-00408-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s44158-026-00408-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s44158-026-00408-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:41:06Z","timestamp":1792633266000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s44158-026-00408-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":98,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["408"],"URL":"https:\/\/doi.org\/10.1186\/s44158-026-00408-5","relation":{},"ISSN":["2731-3786"],"issn-type":[{"value":"2731-3786","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]},"assertion":[{"value":"25 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"EDW received consulting fees from Pacira Biosciences. ML received speaker fees from Advanz Pharma, AOP Pharma, Shionogi, Viatris, and consulting fees from BioMerieux and Previa. EGB and JDU\u00a0serve as Guest Editors of the collection \u201cThe Geriatric Patient Across the Perioperative and Critical Care Continuum: Frailty, Aging and Personalized Management\u201d, to be published in Journal of Anesthesia, Analgesia and Critical Care (JAACC). EGB currently serves as the President of the Italian Society of Anesthesia, Analgesia, Resuscitation and Intensive Care (SIAARTI).\u00a0PMW received consulting fees from Wolters Kluwer\/UpToDate and Viatris. All other authors report no potential conflicts of interest.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"133"}}